Lupin launches Meloxicam Capsules

Meloxicam Capsules is indicated for the management of osteoarthritis (OA) pain.

80
Medicine Capsule
Picture: Pixabay

Last Updated on December 30, 2020 by The Health Master

Lupin announced the launch of Meloxicam Capsules, 5 mg, and 10 mg, having received an approval from the United States Food and Drug Administration (USFDA).

Meloxicam Capsules, 5 mg and 10 mg, is the generic equivalent of Vivlodex Capsules, 5 mg and 10 mg, of Zyla Life Sciences US, and indicated for the management of osteoarthritis (OA) pain.

Meloxicam Capsules (RLD: Vivlodex) had an annual sales of approximately $11 million in the US (IQVIA MAT October 2020).


Also read | 14 samples out of 746 declared as NSQ in Nov 2020:…


The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram..

Follow and connect with us on Facebook and Linkedin

Go to main website, click here